Objective: USDA-ARS is currently looking for an industrial partner to help commercialize an innovative technology to prevent Eschericia coli (E. coli) disease in swine.
Overview: E. coli is the primary cause of Colibacillosis disease, which causes diarrhea in pigs. In U.S. swine operations, it is two to four times more prevalent than diseases attributed to Salmonella and Actinobacillus--other major bacterial diseases in swine. In 1995, 15 percent of deaths in U.S. nursery and pre-weaned swine were caused by E. coli-related diseases.
Related Technology: ARS researchers have developed and patented (US 5,951,977) a novel competitive exclusion technology to prevent E. coli disease in neonatal and nursery-age pigs. Competitive exclusion technology is the process of growing bacteria in the lab and then giving them to animals to protect against disease-causing bacteria. This technology has the potential to reduce antibiotic use in swine production, resulting in less expensive and safer pork products for consumers.
Industry Type: The ideal partner will be an expert in animal diseases, be interested in licensing the patented technology, be willing to support commercialization both intellectually and financially, and be willing to work toward Food and Drug Administration product approval.
Where: Southern Plains Area; USDA-ARS Food and Feed Safety Research Unit in College Station, Texas.
Laboratory Mission: The mission of the Food and Feed Safety Research Unit is to develop cost-effective means to prevent Salmonella and other harmful pathogens in poultry, swine, cattle, and other livestock.
If your company is interested in learning more about this opportunity, contact our regional technology transfer coordinator:
Bryan Kaphammer USDA-ARS 1201 Oakridge Drive, Suite 150 Fort Collins, CO 80525-5562 npa-spattc@npa.ars.usda.gov
|